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Heteronormativity and prostate cancer: a discussion paper.  
 
Daniel Kelly, Sarah Fry, Dikaios Sakellariou, Sofia Vougioukalou 
 
Abstract: 
Aims and objectives: To discuss the role that heteronormative assumptions play in prostate cancer 
care and how these may be addressed. 
Background: Evidence exists to support the case that LGBT cancer patients are less likely to report 
poor health or self-disclose sexual orientation. Gender-specific cancers, such as prostate cancer, 
evoke particular needs in terms of supportive care. These may include advice about side-effect 
management, treatment choices and social and emotional issues. In this paper we discuss and 
problematize the heteronormative discourse and culture that exists around this cancer. We argue 
that situation may act as a barrier to effective supportive care for gay men. 
Design: Theoretical exploration of heteronormativity against the clinical context of prostate cancer. 
Methods: Scan of relevant evidence combined with discussion. 
Results: The paper posits a number of questions around heteronormativity in relation to cancer 
information provision, supportive care and sexuality and disability more generally. Whilst 
assumptions regarding sexual orientation should be avoided in clinical encounters, this may be 
difficult when heteronormativity dominates.   Existing research supports the ascertain that patient 
experience. 
Conclusion: Sexual orientation and relational models of care should be promoted at the start of 
cancer treatment in an appropriate manner. This can assist in reducing the risks of embarrassment 
or offence to patients or professionals. Service providers should also remain aware of potential bias 
in the provision of information or supportive care resources to men who do not identify as 
exclusively heterosexual. 
Relevance to clinical practice: Awareness of heteronormative assumptions in clinical practice can be 
useful for health professionals engaged in prostate cancer care. This can prevent embarrassment for 
patients and ensure a more equitable provision of support; including men who do not identify as 
heterosexual. 
 
Keywords: sexuality, heteronormativity, cancer, nursing, prostate cancer, inequality, supportive 
care. 
 
Relevance to clinical practice: 
 Clinical practice is shaped by time pressures and provision of care that is directed towards 
the majority. These can lead to assumptions about the sexual preferences of cancer 
patients. When heteronormative assumptions dominate this can lead to embarrassment 
and inequality in provision of support to men who are gay or bisexual.  Cancer service providers should be aware of the culture that exists in their organisations 
and monitor the extent to which heteronormative assumptions are challenged in order to 
promote diversity and equality.  
 Introduction 
Prostate cancer is now the second most frequently diagnosed cancer worldwide. However, in more 
developed countries deaths from prostate cancer are decreasing, as a result of improved treatment 
and better detection (Torre et al, 2015).  Increased survival from, or with, prostate cancer introduces 
new challenges now being addressed under the umbrella term cancer survivorship; a phase of care 
concerned with supporting the chronic side-effects of cancer treatment (Collela and Gejerman, 
2013). In this article, we question the dominance of heteronormative assumptions and invite a more 
open debate about whether cancer services meet the needs of all, rather than the heterosexual 
majority. 
 
 
Heteronormativity and prostate cancer   
The incidence of prostate cancer is increasing and it is inevitable that a proportion of homosexual 
and bisexual men will be diagnosed in their lifetime.  There is concern that for some of these men 
prostate cancer may present particular challenges relating to sexual function (often due to side 
effects of treatment rather than the cancer itself), but also because of the heteronormative bias in 
clinical settings (Asencio et al, 2009). Some men consider impotence because of treatment as an 
inevitable and even acceptable side-effect, whereas others may associate impotence with their 
identity as men (Chapple & Ziebland, 2002). For men who do not identify as heterosexual, there are 
particular issues to consider. One of the most pertinent is the role that heteronormativity plays in 
shaping service provision. 
Heteronormativity has been defined as ͚the hegeŵoŶiĐ disĐursiǀe aŶd ŶoŶdisĐursiǀe Ŷorŵatiǀe 
idealizatioŶ of heteroseǆualitǇ͛ ;Hird, ϮϬϬϰ, p.ϮϳͿ. It rests on several assumptions about human 
sexuality including binary opposites of male/female sexual roles stemming from a heterosexual 
stance. Thus, medical culture may mirror heteronormative discourses by failing to challenge 
assumptions about information needs connected with prostate cancer (information usually created 
by, and directed at, men who identify as heterosexual). Heteronormative assumptions can also be 
more widely pervasive and influence others such as prostate cancer charities, advocacy 
organisations or research funders.  
Until very recent times ;froŵ the ϭϵϲϬ͛s oŶ iŶ the UKͿ there was a reluctance to view gay men as 
equal to heterosexual men (Herek, 2000). Although attitudes are changing, sexual acts between men 
who have sex with other men remain taboo in some circles (McDonagh et al, 2014).  This may be 
reflected in clinical practice, particularly through subtle yet powerful reinforcements such as the 
heteronormative language used in scales to measure quality of life or sexual dysfunction (McDonagh 
et al, 2014) or during specific communication tasks such as assessment of sexual functioning which 
reinforce vaginal penetration (Carr, 2007). 
An example of such an assumption can be seen in the methods for assessment of erectile 
dysfunction after prostate cancer treatment.  It is well documented that the outcomes of such 
treatments can include problems with sexual functioning, such as erectile dysfunction, penile 
shrinkage and loss of libido (Blank, 2005; Asencio et al, 2009), as well as potential damage to the 
pelvic floor causing urinary and faecal incontinence (often as a result of surgical intervention and 
radiotherapy).   Discussions about sexual dysfunction after prostate cancer treatment commonly 
focus on the assessment of erectile (dys)function, however, based on the assumption the penis 
should be erect enough to achieve and maintain vaginal penetration; which fails to recognise a 
group of men for whom vaginal penetration may not be a concern.  For sexually active gay men, oral 
or anal penetration may be more concerning when sexual activity is assessed, and for men who are 
anally receptive concerns will centre more on the late effects of radiotherapy on the bowel, 
including abdominal pain, dietary advice or diarrhoea management (Blank, 2005).   
Since the introduction of Viagra in 1998 conversations about erectile dysfunction have become part 
of normative speech in prostate practice (Incrocci, 2011), however conversations about oral sex or 
anal penetration remain more taboo in everyday clinical discourse.   The difficulty clinicians may face 
in asking men who have sex with men (MSM) about their sexuality is often reflected in the 
relationships gay or bisexual men establish with their healthcare professionals (Blank, 2005).  Gay 
and bisexual men may feel they need to tread carefully with heterosexually-orientated clinicians, 
with the associated worry of experiencing subtle or overt homophobia. These fears may, in turn, 
evoke feelings of isolation and embarrassment that can be implicated in late presentation of cancer 
symptoms (Jowett and Peel, 2009). The impact of heteronormativity, therefore, goes beyond 
attitudes and can play an important a role in how MSM feel about presenting to a healthcare 
professional with symptoms. Expert nurses have a crucial role to play in challenging negative 
stereotypes and spearheading practice that promotes equality and diversity in cancer care.   
 
The professional response 
 
The remit of the Clinical Nurse Specialist, Advanced Practitioner or Consultant Nurse roles has 
expanded greatly over the last thirty years and now more commonly involves the giving of a prostate 
cancer diagnosis and ongoing psychosocial support (Tarrant et al 2008).  This is happening because 
their remit is to support the patient and their family and, in the UK context, because of the 
requirement for each cancer patient to be assigned a key worker at diagnosis.  However, confirming 
a cancer diagnosis can evoke anxiety for the nurse about communicating with sensitivity but also 
with authority so that the patient has confidence feels secure.  This is a skill which takes some time 
to master, as does a conversation with a patient about sexual dysfunction. There is evidence that 
such conversations may not take place- even in consultations involving prostate cancer patients 
(Forbat et al 2012). In this study, consultations between doctors and patients were observed, 
comparative studies are now needed to establish whether nurses are able to address psychosexual 
concerns more effectively. 
However, in busy clinical situations it may surprise or sometimes embarrasses men when sex is 
mentioned suddenly during a consultation.  It is reasonable to suggest that maturity and experience 
will be required on the part of the nurse to choose the best time to move the conversation on from 
initial embarrassment to uncover how the man really feels about their cancer, sexual recovery or 
adjustment to a new reality that incorporates some degree of sexual dysfunction.   
It is also reasonable to assume that most professionals are not homophobic; instead they may feel 
that it is safer to discuss erectile dysfunction in the context of virginal penetration, particularly 
because there will be clear guidelines regarding onward referral for the patient and the treatment 
options that can be offered, when required.   
For the wider cancer care community there is a need to understanding the wider context for gay and 
bisexual men and opportunities need to be given to nurses to explore and challenge any 
preconceptions they may hold about men who have sex with other men.   
This process could start by involving nurses with the gay and bisexual community to become better 
informed about lifestyle choices, including sexual activity, so that a conversation can be had at 
diagnosis about which aspect of treatment is going to affect men the most, and where and when the 
best support can be offered.  Gay professionals themselves have contributed to this change process 
by adding their own views to the literature (Cornell 2005). 
Gay men are only one of the groups whose sexual lives may be treated with some degree of taboo 
by health providers. Disabled people may face similar prejudice and it is important to consider the 
wider impact on these groups in order to compare inequalities in different contexts. 
 
 
Who is allowed to be sexual? 
 
Despite recognition of the needs and rights of disabled people1 and people living with illness to 
sexuality, many healthcare professionals report reluctance to address sexuality (Esmail, Darry, 
Walter, and Knupp 2010). Much of this reluctance can be traced to social discourses that limit the 
right to sexuality to an idealized young, heterosexual, able-bodied male and subsequently deny the 
sexuality of those who do not fit in this model (Tepper 2000). 
 
Sexuality relates to how people behave, the choices they make, and to who and what they desire 
(Weeks 2002). Sexuality is often considered to be a deeply personal matter, unique to each 
individual. Historically, sexual desire has ďeeŶ seeŶ as ͞Ŷatural and automatic and heterosexual and 
uŶiǀersal͟ (Gagnon and Parker 1995, p. 12), while sex has often been viewed as ͞a priǀilege of the 
white, heterosexual, young, single, non-disaďled͟ ;Tepper 2000, p.285) people. The perception of 
sexuality as a normative construct was problematized and ultimately deconstructed as a result of the 
social traŶsforŵatioŶs of the ϭϵϳϬ͛s ;e.g. the gay rights movement and the feminist movement). 
 
For several years, understandings of disability and illness were influenced by the medical model. 
According to this model, the causes of illness and disability are located within the biological body 
(Stroman 2003). The social model of disability has reframed illness and disability as a dynamic 
relationship between people with an impairment or other health condition and their environment 
(Shakespeare & Watson, 2001; Stroman 2003). The social model of disability has helped relocate the 
emphasis from individual bodies to the social environment within people live (Stroman 2003). 
Similar perspectives can be seen in the context of gay men where the individual requirement for 
prostate cancer support eventually becomes a wider social concern about inequalities. 
Nonetheless, persons who do not fit the able-bodied/heterosexual norm are often placed in invisible 
or marginalised spaces in the clinical arena, they are viewed as powerless people who need to be 
protected, or as simply asexual (Sakellariou 2006). Debates about sexuality are fundamentally 
debates about freedom of choice; they concern people͛s ability to live the life they want to live- this 
does not stop when prostate cancer is diagnosed. The question we need to ask is what is permissible 
                                                          
1 Our use of the term disabled people is informed by critical disability studies, and we use it with the 
explicit intent to draw attention to the fact that disability and illness are not personal characteristics, 
but the outcome of a process, through which a person becomes disabled.  
and what is not? In the words of Weeks (2002, p113), ͞What can be said or performed by whom in 
what circumstances (...)͟?  
Sexuality is controlled through systems of gender and class, often functioning as a mirror of wider 
social attitudes towards difference. This can be shown, for example, through the ableism and 
heteronormativity that underpin institutions like marriage (although this is now changing in several 
countries), church, employment and health professions, as several studies from the last decade 
illustrate (Jackson 2000, Röndahl et al 2006, Weeks 2002).  
The depiction of sexuality and cancer as exclusive identities supports a mono-dimensional depiction 
of men with prostate cancer as asexual service users who lack agency. When social behaviours and 
manifestations of sexuality are controlled by an intricate nexus of expectations and beliefs, sexuality 
can be understood as a state rather than a possibility, and people who do not fit into this ideal can 
be considered to be asexual (Sakellariou 1006; 2012). However, can we ever talk of one correct 
sexuality in the cancer clinic with confidence? Once again, the evidence would suggest that it is not a 
topic explored routinely- even in setting where men, who have been diagnosed with cancer, are 
being reviewed (Forbat et al 2012). 
Male sexuality is commonly viewed as phallocentric, reinforcing the centrality of physical 
performance (Drench 1992, Shakespeare, 2000). This can cause feeling of inadequacy and even 
emasculation to men with prostate cancer. As Shuttleworth, Wedgwood and Wilson (2012, p.174) 
poiŶt out there is ofteŶ a perĐeptioŶ that ͞ŵasĐuliŶitǇ aŶd disaďilitǇ are iŶ ĐoŶfliĐt ǁith eaĐh other 
because disability is associated with being dependent and helpless whereas masculinity is associated 
with ďeiŶg poǁerful aŶd autoŶoŵous͟. Sexuality, however, is not based only on this mechanistic 
view of penile strength and function (Milligan & Neufeldt 2001; Tepper 2000), but it can also be 
understood in terms of emotional closeness and also pleasure. While physical performance is one of 
the ways through which people can achieve sexual pleasure, pleasure can also be achieved through 
a variety of other, non performance-based, ways. 
 
The problem of introducing sex into clinical settings is reinforced in several studies including the 
auto ethnographic Teratologies, by Stacey in 1997. This provided, amongst many other rich insights 
from an auto-ethnography of ovarian cancer, a Foucauldian interpretation of visual constructions of 
cancer. Both the culture and practice of medicine were altered when it became possible to map the 
internal body so precisely: 
 
͚The ĐliŶiĐal gaze, ǁhiĐh is takeŶ for graŶted iŶ ĐoŶteŵporarǇ WesterŶ Đulture, is Ŷot the 
inevitable outcome of scientific progress or technological invention, but rather originated in 
a very specific medical culture in which the discourse of visibility became central. The clinic is 
a place primarily of vision and observation: doctors learn to see, to isolate, to recognise, to 
Đoŵpare aŶd thus to ŵatĐh ;or ŶotͿ, to sĐrutiŶise aŶd theŶ to iŶterǀeŶe͛. ;Stacey, 1997, p.55) 
 
In prostate cancer, tumours are literally ͚opeŶed up͛ to sĐrutiŶǇ iŶ the radiotherapǇ departŵeŶt 
through a combination of technologies such as computerised scans, X rays, tissue biopsies and blood 
tests. Novel technologies are emerging constantly which allow images, and radiation therapy, to be 
panned and rotated in three dimensions similar to what occurs in geophysics and astronomy. 
Mathematical modelling can also be used to calculate the dosage of radiotherapy required to 
aĐhieǀe ŵaǆiŵuŵ ͚Đell kill͛. 
In such a culture there is a jarring with the emotional and private/sexual self and may go some way 
to explain the dominance and popularity of heteronormative discourses. To enter any other sphere 
of human sexuality may be seen as risky in such a scientific arena. 
 
The impact of heteronormative inequality on prostate cancer care 
 
The Inquiry into Inequalities in Cancer (All Party Parliamentary Group on CaŶĐer͛s, 2009) reported 
that in the UK gay men have a greater incidence of anal cancer and cancers related to HIV/AIDS. 
However, we do not know whether there is also a difference in the incidence of prostate cancer 
between gay and bisexual men and the general populatioŶ. “toŶeǁall͛s surǀeǇ of the health needs of 
gay and bisexual men, reported that 10% of gay and bisexual men of all ages have discussed prostate 
cancer with a healthcare provider, while 68 % of gay and bisexual men over the age of 50 have not 
discussed this issue. This is slightly lower compared to men in general (Prostate Cancer UK and 
Stonewall 2013: 8). 
 
Gay men have reported that healthcare professionals do not always ask about sexual orientation in 
initial consultations, making an assumption of heterosexuality (Mitteldorf 2005). Furthermore, men 
with prostate cancer have reported not disclosing their sexual orientation to healthcare 
professionals due to a concern about negative reactions (Filiault et al 2008) or because they think 
the clinical relevance of their sexual orientation will be disregarded (Katz 2009). In the most recent 
Cancer Patient Experience Survey, respondents who identified as non-heterosexual, reported more 
negative experiences regarding communication, respect and dignity in relation to treatment, care 
and information within the National Health Service in the UK (Department of Health 2012). A survey 
on gay and bisexual meŶ͛s health highlighted that 30% of gay and bisexual men who accessed health 
services in a period of one year have had a negative experience related to their sexuality (Stonewall 
2013). 
 
A small online focus group study lasting four weeks (Thomas et al 2013) confirmed the earlier points 
that emotional reactions to the diagnosis was closely linked with having access to information and 
support. Other factors that emerged included the role of sexual changes on sense of self, a re-
evaluation of life and the need to find the most suitable health professional who could explore their 
current and ongoing needs. By doing so there was agreement that this improved the overall quality 
of care. 
 
Critical illness not only presents patients with issues of finitude, but more importantly, it threatens 
the very foundation of time structuring by reŵoǀiŶg patieŶts froŵ life͛s ĐoŵfortiŶg rhǇthŵs. BrǇsoŶ 
argues that cancer survivorship is inextricable from surviving not only other serious medical traumas 
but also from surviving in a normative culture that has yet to accommodate diverse sexualities 
(Stacey and Bryson 2012). Even though normative ideals of masculinity still affect how 
Men understand their health and their risk of prostate cancer, the encounter with healthcare 
professionals needs to be able to accommodate diversity of expression and needs. The findings of 
Thomas et al (2013) and Forbat et al (2012) confirm this assertion. 
 
Experiences of heteronormative discourse and practices can be particularly harmful to the 
psychological wellbeing of patients when disease affects reproductive organs and/or function. On 
these occasions, patients have to adapt to the short-term side-effects of treatment as well as the 
long-term psychosocial effects on sexual function. Competent healthcare should be dependent upon 
a reĐogŶitioŶ that geŶder ĐaŶ haǀe aŶ iŵpaĐt oŶ a persoŶ͛s ǁellďeiŶg aŶd failure to address those 
differences can accentuate existing health inequalities (Peate 2011), which is against existing 
national guidelines on health equity. The Cancer Reform Strategy (Department of Health 2009) 
discusses the requirement that every person affected by cancer should receive world-class services 
at each stage of the disease and its treatment. Despite this, there remain inequalities between 
different groups of people in terms of incidence, access to services and treatment, patient 
experience and outcomes (Boehmer et al 2011).  
 
Participatory design approach (PDA) of support services for non-heterosexual men may offer one 
approach to ensure that personal experience can be used to challenge aspects of services that do 
meet the needs of MSM (Al-Itejawi et al 2105). Such approaches employ a step-wise approach of 
focus groups on usability at the pre-conceptual, prototype and usability phase. The challenge facing 
health service researchers now is to recruit men to such studies and explore their needs in the face 
of the negative attitudes that may exist in some settings. However, doing so holds the promise of 
change.  
 
 
Conclusion 
It is important to close the gap in sexuality-based inequalities in cancer treatment. This will require 
the concerted effort of different organisations. Some of the strategies that are required include: 
networking between cancer and gay organisations to share good practice but also learn from 
negative experiences; developing resources for support groups; and developing resources (e.g. 
training materials) for health professionals, educating them about the importance of sexual 
orientation. 
A first step in this process is to recognise the negative risks associated with heteronormative 
attitudes and to question the extent to which cancer services ignore the needs of those who do 
identify as heterosexual. This paper has proposed the argument that change can be achieved by 
drawing on existing evidence, reviewing the experiences of gay men themselves and making 
comparisons with other marginalised groups who may also be at risk of inequity during cancer. 
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